Whole slide | Tissuepathology.com

Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists

Erica Goodpaster — Thu, 18 Jun 2026 15:22:57 +0000

PHILADELPHIA — June 17, 2026 — Proscia® today introduced the Fifth Generation of its Concentriq®[1] platform, helping pathologists focus on high-judgment decisions and enabling scientists to quickly move from early signals to evidence-based program decisions. Proscia is trusted by diagnostic laboratories that manage 12 million patient cases annually, and 16 of the top 20 pharmaceutical companies. Pathology sits […]

The post Proscia Launches Fifth Generation of Concentriq, Bringing the Latest Advancements in AI to Pathologists and Scientists first appeared on Tissuepathology.com.

ASCO: Now and Then

Dr. Keith J. Kaplan — Thu, 11 Jun 2026 18:00:28 +0000

In medical school I drove a cab at night to make ends meet. I rented the medallion from a guy for $50 and kept the difference I made. The Army paid me $692 a month stipend on the Health Professions Scholarship and the studio apartment in downtown Chicago was $1000/month. I wasshort over $300 a […]

The post ASCO: Now and Then first appeared on Tissuepathology.com.

Proscia: From Glass Slide to Molecular Proxy: The Pathology AI Convergence at AACR 2026

Erica Goodpaster — Tue, 12 May 2026 11:51:45 +0000

From the Proscia blog: We’ve long said that the next major therapeutic breakthrough may lie in pathology data that already exists. At this year’s AACR Annual Meeting, it became clear the biopharma community is arriving at the same conclusion. Across more than 7,000 abstracts presented in San Diego, multiple independent groups demonstrated that AI applied […]

The post Proscia: From Glass Slide to Molecular Proxy: The Pathology AI Convergence at AACR 2026 first appeared on Tissuepathology.com.

Aiforia closes a deal with a private diagnostic laboratory in Italy

Erica Goodpaster — Thu, 23 Apr 2026 12:22:10 +0000

Using Aiforia Create, the laboratory La Fontana aims to develop deep learning AI models for analyzing cervical cancer samples. Aiforia Technologies Plc, Press Release, April 23, 2026, at 11:00 a.m. EEST Aiforia Technologies Plc has signed an agreement with Laboratorio di Analisi La Fontana, a private diagnostic laboratory in Italy, to collaborate in AI-powered digital pathology. […]

The post Aiforia closes a deal with a private diagnostic laboratory in Italy first appeared on Tissuepathology.com.

Pictor Labs Introduces On-Prem Deployment for Virtual Stains at USCAP 2026

Erica Goodpaster — Mon, 06 Apr 2026 13:05:44 +0000

Pictor Labs: AI-Powered Virtual Staining Can Now Run Directly Within Pathology Labs First-to-market, production-ready On-Prem deployment system enables secure, high-speed virtual staining without transmitting data to external cloud infrastructure Visit Pictor Labs at Booth #749 for a hands-on demonstration LOS ANGELES, March 23, 2026 /PRNewswire/ — Pictor Labs, the virtual staining company, enabling digital pathology adoption worldwide, today […]

The post Pictor Labs Introduces On-Prem Deployment for Virtual Stains at USCAP 2026 first appeared on Tissuepathology.com.

Ataraxis AI Launches Ataraxis Breast CTX, the First Predictive AI Test Estimating Individualized Chemotherapy Benefit in Breast Cancer

Erica Goodpaster — Tue, 31 Mar 2026 13:37:57 +0000

NEW YORK–(BUSINESS WIRE)–Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis™ Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients. Ataraxis Breast combines digitized H&E pathology slides with clinical data to generate prognostic and […]

The post Ataraxis AI Launches Ataraxis Breast CTX, the First Predictive AI Test Estimating Individualized Chemotherapy Benefit in Breast Cancer first appeared on Tissuepathology.com.